NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort
- PMID: 17968944
- DOI: 10.1002/art.22966
NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort
Abstract
Objective: Blau syndrome and early-onset sarcoidosis are NOD2 gene-associated chronic autoinflammatory diseases characterized by skin rash, arthritis, and/or eye involvement, with noncaseating granulomata as their pathologic hallmark. This study was undertaken to describe the expanded clinical phenotype, treatment outcomes, and NOD2 gene mutation analysis in a Spanish cohort with pediatric granulomatous arthritis, a chronic disease resembling Blau syndrome/early-onset sarcoidosis.
Methods: Clinical, laboratory, and treatment data on the 12 patients in the cohort were obtained through direct interviews. NOD2 gene analysis was performed in a central laboratory, by bidirectional sequencing. Cytokine levels were measured using the human Flex-Set cytokine bead array.
Results: The classic Blau syndrome/early-onset sarcoidosis triad of skin rash, arthritis, and recurrent uveitis was identified in 5 patients (41.7%), whereas 7 patients (58.3%) presented with fewer than 3 of the classic features. Novel atypical manifestations such as persistent fever and myocardiopathy were also observed. NOD2 analysis revealed 1 heterozygous mutation in each patient, and familial studies confirmed its full penetrance. Of the 12 cases, 58.3% were sporadic, due to de novo mutations. Four different missense mutations on exon 4 were detected. Two of them (R334W and R334Q) were recurrent mutations and were found in 77.8% of the Spanish families, whereas the other 2 (C495Y and R587C) were novel. In the patient who received anakinra treatment, all clinical inflammatory symptoms improved and plasma cytokine levels normalized.
Conclusion: These findings indicate that the expanding clinical heterogeneity of the disease (that is, the presentation of incomplete forms of the classic triad and atypical manifestations) and the high prevalence of sporadic cases should alert clinicians to the possible genetic basis of the condition and support the inclusion of DNA analysis as a diagnostic test. The positive response to anakinra observed in 1 patient suggests a new potential therapeutic approach that merits further investigation, and suggests that the pathogenesis of pediatric granulomatous arthritis may involve interleukin-1-mediated events.
Similar articles
-
Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.Arthritis Rheum. 2009 Jan;60(1):242-50. doi: 10.1002/art.24134. Arthritis Rheum. 2009. PMID: 19116920
-
A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.Scand J Rheumatol. 2009 May-Jun;38(3):190-7. doi: 10.1080/03009740802464194. Scand J Rheumatol. 2009. PMID: 19169908
-
Pediatric granulomatous arthritis: an international registry.Arthritis Rheum. 2006 Oct;54(10):3337-44. doi: 10.1002/art.22122. Arthritis Rheum. 2006. PMID: 17009307
-
Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation.Ophthalmology. 2003 Oct;110(10):2040-4. doi: 10.1016/S0161-6420(03)00717-6. Ophthalmology. 2003. PMID: 14522785 Review.
-
NOD2-associated diseases: Bridging innate immunity and autoinflammation.Clin Immunol. 2010 Mar;134(3):251-61. doi: 10.1016/j.clim.2009.05.005. Epub 2009 May 24. Clin Immunol. 2010. PMID: 19467619 Review.
Cited by
-
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.Mediators Inflamm. 2015;2015:194864. doi: 10.1155/2015/194864. Epub 2015 Feb 16. Mediators Inflamm. 2015. PMID: 25784780 Free PMC article. Review.
-
The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.Arthritis Rheum. 2009 Feb;60(2):611-8. doi: 10.1002/art.24222. Arthritis Rheum. 2009. PMID: 19180500 Free PMC article.
-
NOD-like receptors and inflammation.Arthritis Res Ther. 2008;10(6):228. doi: 10.1186/ar2525. Epub 2008 Nov 25. Arthritis Res Ther. 2008. PMID: 19090963 Free PMC article. Review.
-
Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature.Arch Rheumatol. 2019 Nov 6;35(1):117-127. doi: 10.5606/ArchRheumatol.2020.7060. eCollection 2020 Mar. Arch Rheumatol. 2019. PMID: 32637927 Free PMC article.
-
Blau syndrome with hypertension and hepatic granulomas: a case report and literature review.Front Pediatr. 2023 Jul 27;11:1063222. doi: 10.3389/fped.2023.1063222. eCollection 2023. Front Pediatr. 2023. PMID: 37576148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical